Harvard Management Company stated in its 13-F Form that it sold 483,590 shares in Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA ; TASE: TEVA ) for $30.5 million; 52,360 shares in NICE Systems Ltd. (Nasdaq: NICE ; TASE: NICE ) for $1.67 million; 102,940 shares in Check Point Software Technologies Ltd. (Nasdaq: CHKP ) for $3.6 million; 32,400 shares in Cellcom Israel Ltd. (NYSE:CEL ; TASE:CEL ) for $1.1 million, and 80,000 Partner Communications Ltd. (Nasdaq: PTNR ; TASE: PTNR ) shares for $1.8 million.
Harvard Management Company’s 13-F Form shows some interesting investments. Its two largest holdings, each worth $295 million, are in iShares ETFs, one on Chinese equities, and the other on emerging markets. Harvard also owns $181 million in a Brazilian ETF.
http://www.globes.co.il/serveen/globes/docview.asp?did=1000581912&fid=1725